Displaying 38 results
| Age | Gender | Blood Type | Medication | Test Results | Insurance | AdmissionType |
|---|---|---|---|---|---|---|
| 25 | Female | AB+ | Lipitor | Abnormal | Medicare | Elective |
| 26 | Female | B- | Ibuprofen | Abnormal | Medicare | Emergency |
| 27 | Female | B- | Ibuprofen | Inconclusive | Aetna | Elective |
| 18 | Female | AB+ | Lipitor | Inconclusive | Blue Cross | Urgent |
| 26 | Female | AB+ | Penicillin | Inconclusive | Blue Cross | Urgent |
| 29 | Female | B+ | Paracetamol | Inconclusive | Cigna | Urgent |
| 22 | Female | O+ | Aspirin | Inconclusive | Aetna | Elective |
| 30 | Female | O+ | Ibuprofen | Abnormal | Medicare | Emergency |
| 18 | Female | A+ | Penicillin | Normal | UnitedHealthcare | Emergency |
| 19 | Female | B- | Lipitor | Abnormal | Medicare | Emergency |
| 21 | Female | O- | Aspirin | Abnormal | Aetna | Elective |
| 21 | Female | O- | Lipitor | Abnormal | Aetna | Elective |
| 22 | Female | B+ | Penicillin | Abnormal | Cigna | Emergency |
| 29 | Female | B- | Ibuprofen | Normal | Cigna | Emergency |
| 18 | Female | B- | Aspirin | Normal | Blue Cross | Emergency |
| 21 | Female | O+ | Aspirin | Normal | Aetna | Emergency |
| 20 | Female | O- | Ibuprofen | Inconclusive | Medicare | Emergency |
| 21 | Female | O+ | Penicillin | Normal | Aetna | Elective |
| 21 | Female | B- | Ibuprofen | Inconclusive | Blue Cross | Emergency |
| 26 | Female | B+ | Aspirin | Normal | Cigna | Emergency |
| 27 | Female | AB- | Penicillin | Normal | Medicare | Urgent |
| 28 | Female | O+ | Aspirin | Abnormal | Medicare | Elective |
| 30 | Female | A+ | Paracetamol | Normal | Aetna | Elective |
| 29 | Female | O- | Penicillin | Normal | Medicare | Urgent |
| 30 | Female | B- | Aspirin | Abnormal | Aetna | Elective |
| 29 | Female | AB- | Ibuprofen | Normal | Aetna | Urgent |
| 27 | Female | AB+ | Aspirin | Normal | Aetna | Urgent |
| 27 | Female | O- | Aspirin | Normal | Blue Cross | Emergency |
| 25 | Female | B+ | Ibuprofen | Inconclusive | Medicare | Elective |
| 27 | Female | O- | Penicillin | Normal | UnitedHealthcare | Emergency |
| 19 | Female | A- | Ibuprofen | Inconclusive | Medicare | Emergency |
| 18 | Female | B- | Aspirin | Abnormal | UnitedHealthcare | Elective |
| 20 | Female | O+ | Paracetamol | Abnormal | Medicare | Emergency |
| 23 | Female | B+ | Lipitor | Inconclusive | Cigna | Elective |
| 27 | Female | A- | Ibuprofen | Inconclusive | Aetna | Elective |
| 27 | Female | O+ | Paracetamol | Inconclusive | Blue Cross | Urgent |
| 18 | Female | O- | Penicillin | Normal | UnitedHealthcare | Elective |
| 30 | Female | B- | Paracetamol | Abnormal | Cigna | Emergency |
Displaying 26 results
| Gender | InsuranceProvider | Test Results | Times Occured |
|---|---|---|---|
| Female | Aetna | Abnormal | 3 |
| Female | Aetna | Inconclusive | 3 |
| Female | Aetna | Normal | 5 |
| Male | Aetna | Abnormal | 3 |
| Male | Aetna | Inconclusive | 5 |
| Male | Aetna | Normal | 2 |
| Female | Blue Cross | Inconclusive | 4 |
| Female | Blue Cross | Normal | 2 |
| Male | Blue Cross | Abnormal | 5 |
| Male | Blue Cross | Inconclusive | 1 |
| Male | Blue Cross | Normal | 4 |
| Female | Cigna | Abnormal | 2 |
| Female | Cigna | Inconclusive | 2 |
| Female | Cigna | Normal | 2 |
| Male | Cigna | Abnormal | 3 |
| Male | Cigna | Inconclusive | 5 |
| Female | Medicare | Abnormal | 6 |
| Female | Medicare | Inconclusive | 3 |
| Female | Medicare | Normal | 2 |
| Male | Medicare | Abnormal | 5 |
| Male | Medicare | Normal | 5 |
| Female | UnitedHealthcare | Abnormal | 1 |
| Female | UnitedHealthcare | Normal | 3 |
| Male | UnitedHealthcare | Abnormal | 1 |
| Male | UnitedHealthcare | Inconclusive | 3 |
| Male | UnitedHealthcare | Normal | 1 |
Based on the data analysis of 38 female asthma patients aged 18-30:
The average age of patients in this cohort is 24.2 years
Total healthcare costs for this group reached $11,052,310.30
Average billing per patient was $26,315.02
The data provides a mixed picture of diagnostic outcomes. Among Aetna patients, men recorded more inconclusive results (5 cases) than women (3 cases), while women had a slightly higher number of normal results (5 vs 2). For Blue Cross, women experienced more inconclusive outcomes (4 cases) compared to men (1 case), though men showed more abnormal results (5 vs none reported for women). This supports our hypothesis that women may be more affected by inconclusive testing under certain insurers.
At Cigna, men again reported more inconclusive results (5 cases) than women (2 cases), while abnormal results were slightly higher for men (3 vs 2). Medicare showed both genders with high abnormal results, though females had slightly more (6 vs 5), while inconclusive results were only reported among women (3 cases). UnitedHealthcare revealed the opposite trend: men recorded more inconclusive results (3 vs none among women), while women showed a greater share of normal results (3 vs 1).
Conclusion:Overall, these findings suggest that the hypothesis is only somewhat supported. Women did experience more inconclusive results under Blue Cross and Medicare, but under Aetna, Cigna, and UnitedHealthcare the pattern was reversed or more balanced. This indicates that diagnostic disparities do exist, but they vary significantly by insurance provider rather than reflecting an overall gender-based pattern.